Dependence of GnRH-induced phosphorylation of CREB and BAD on EGF receptor transactivation in GT1-7 neuronal cells

Journal of Cellular Physiology

Volumn 208, Issue 3, 2006, Pages 586-593

  Neithardt, Adrienne ^a   Farshori, M Parvaiz ^a   Shah, Farzana B ^a   Catt, Kevin J ^a   Shah, Bukhtiar H ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; CELL PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GONADORELIN; GONADORELIN DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROPEPTIDE; NUCLEAR PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN BAD; PROTEIN KINASE B; S6 KINASE;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN GT1 7; CELL SURVIVAL; CONTROLLED STUDY; CYTOSOL; GENE OVEREXPRESSION; HORMONAL REGULATION; HORMONE ACTION; HYPOTHALAMUS; MITOGENESIS; MOLECULAR MIMICRY; MOUSE; NERVE CELL; NERVE CELL STIMULATION; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REPRODUCTION; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ANIMALS; BCL-ASSOCIATED DEATH PROTEIN; CELL LINE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; EPIDERMAL GROWTH FACTOR; GONADOTROPIN-RELEASING HORMONE; HYPOTHALAMUS; MICE; NEURONS; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 33746547892     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20697     Document Type: Article

References (51)

1. Anderson KE, Jackson SP. 2003. Class I phosphoinositide 3-kinases. Int J Biochem Cell Biol 35(7):1028-1033.
2. Andrisani OM. 1999. CREB-mediated transcriptional control. Crit Rev Eukaryot Gene Expr 9(1):19-32.
3. Benard O, Naor Z, Seger R. 2001. Role of dynamin, Src, and Ras in the protein kinase C-mediated activation of ERK by gonadotropin-releasing hormone. J Biol Chem 276(7):4554-4563.
4. Bergmann A. 2002. Survival signaling goes BAD. Dev Cell 3(5):607-608.
5. Buck M, Poli V, Hunter T, Chojkier M. 2001. C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival. Mol Cell 8(4):807-816.
6. Cantley LC. 2002. The phosphoinositide 3-kinase pathway. Science 296(5573):1655-1657.
7. Cantrell DA. 2001. Phosphoinositide 3-kinase signalling pathways. J Cell Sci 114(Pt 8):1439-1445.
8. Cesnjaj M, Krsmanovic LZ, Catt KJ, Stojilkovic SS. 1993. Autocrine induction of c-fos expression in GT1 neuronal cells by gonadotropin-releasing hormone. Endocrinology 133(6):3042-3045.
9. Chen A, Kaganovsky E, Rahimipour S, Ben-Aroya N, Okon E, Koch Y. 2002. Two forms of gonadotropin-releasing hormone (GnRH) are expressed in human breast tissue and overexpressed in breast cancer: A putative mechanism for the antiproliferative effect of GnRH by down-regulation of acidic ribosomal phosphoproteins P1 and P2. Cancer Res 62(4):1036-1044.
10. Coutant A, Rescan C, Gilot D, Loyer P, Guguen-Guillouzo C, Baffet G. 2002. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival. Hepatology 36(5):1079-1088.
11. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91(2):231-241.
12. Datta SR, Ranger AM, Lin MZ, Sturgill JF, Ma YC, Cowan CW, Dikkes P, Korsmeyer SJ, Greenberg ME. 2002. Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis. Dev Cell 3(5):631-643.
13. Emons G, Schally AV. 1994. The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers. Hum Reprod 9(7):1364-1379.
14. Filicori M. 1994. Gonadotrophin-releasing hormone agonists. A guide to use and selection. Drugs 48(1):41-58.
15. Frodin M, Gammeltoft S. 1999. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 151(1-2):65-77.
16. Gilmore AP, Valentijn AJ, Wang P, Ranger AM, Bundred N, O'Hare MJ, Wakeling A, Korsmeyer SJ, Streuli CH. 2002. Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor. J Biol Chem 277(31):27643-27650.
17. Grosse R, Schmid A, Schoneberg T, Herrlich A, Muhn P, Schultz G, Gudermann T. 2000. Gonadotropin-releasing hormone receptor initiates multiple signaling pathways by exclusively coupling to G(q/11) proteins. J Biol Chem 275(13):9193-9200.
18. Han XB, Conn PM. 1999. The role of protein kinases A and C pathways in the regulation of mitogen-activated protein kinase activation in response to gonadotropin-releasing hormone receptor activation. Endocrinology 140(5):2241-2251.
19. Johannessen M, Delghandi MP, Moens U. 2004. What turns CREB on? Cell Signal 16(11):1211-1227.
20. Kraus S, Naor Z, Seger R. 2001. Intracellular signaling pathways mediated by the gonadotropin-releasing hormone (GnRH) receptor. Arch Med Res 32:499-509.
21. Krsmanovic LZ, Martinez-Fuentes AJ, Arora KK, Mores N, Navarro CE, Chen HC, Stojilkovic SS, Catt KJ. 1999. Autocrine regulation of gonadotropin- releasing hormone secretion in cultured hypothalamic neurons. Endocrinology 140(3):1423-1431.
22. Laffargue M, Raynal P, Yart A, Peres C, Wetzker R, Roche S, Payrastre B, Chap H. 1999. An epidermal growth factor receptor/Gab1 signaling pathway is required for activation of phosphoinositide 3-kinase by lysophosphatidic acid. J Biol Chem 274(46):32835-32841.
23. Lawlor MA, Alessi DR. 2001. PKB/Akt: A key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114(Pt 16):2903-2910.
24. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372(6508):739-746.
25. Liu F, Austin DA, Mellon PL, Olefsky JM, Webster NJ. 2002. GnRH activates ERK1/2 leading to the induction of c-fos and LHbeta protein expression in LbetaT2 cells. Mol Endocrinol 16(3):419-434.
26. Mantamadiotis T, Kretz O, Ridder S, Bleckmann SC, Bock D, Grone HJ, Malaterre J, Dworkin S, Ramsay RG, Schutz G. 2006. Hypothalamic CREB loss causes anterior pituitary hypoplasia and dwarfism in mice. Mol Endocrinol. 20:204-211.
27. Marelli MM, Moretti RM, Dondi D, Motta M, Limonta P. 1999. Luteinizing hormone-releasing hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cells. Endocrinology 140(1):329-334.
28. Mellon PL, Windle JJ, Goldsmith PC, Padula CA, Roberts JL, Weiner RI. 1990. Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron 5(1):1-10.
29. Millar RP, King JA, Davidson JS, Milton RC. 1987. Gonadotrophin-releasing hormone-diversity of functions and clinical applications. S Afr Med J 72(11):748-755.
30. Millar RP, Lu ZL, Pawson AJ, Flanagan CA, Morgan K, Maudsley SR. 2004. Goriadotropin-releasing hormone receptors. Endocr Rev 25(2):235-275.
31. Miller WR, Scott WN, Morris R, Fraser HM, Sharpe RM. 1985. Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature 313(5999):231-233.
32. Mulvaney JM, Roberson MS. 2000. Divergent signaling pathways requiring discrete calcium signals mediate concurrent activation of two mitogen-activated protein kinases by gonadotropin-releasing hormone. J Biol Chem 275(19):14182-14189.
33. Oikawa M, Dargan C, Ny T, Hsueh AJ. 1990. Expression of gonadotropin-releasing hormone and prothymosin-alpha messenger ribonucleic acid in the ovary. Endocrinology 127(5):2350-2356.
34. Palmon A, Ben Aroya N, Tel-Or S, Burstein Y, Fridkin M, Koch Y. 1994. The gene for the neuropeptide gonadotropin-releasing hormone is expressed in the mammary gland of lactating rats. Proc Natl Acad Sci USA 91(11):4994-4996.
35. Rose A, Froment P, Perrot V, Quon MJ, LeRoith D, Dupont J. 2004. The luteinizing hormone-releasing hormone inhibits the anti-apoptotic activity of insulin-like growth factor-1 in pituitary alphaT3 cells by protein kinase Calpha-mediated negative regulation of Akt. J Biol Chem 279(50):52500-52516.
36. Sassone-Corsi P, Mizzen CA, Cheung P, Crosio C, Monaco L, Jacquot S, Hanauer A, Allis CD. 1999. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science 285(5429):886-891.
37. Schlessinger J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103(2):211-225.
38. Shah BH, Catt KJ. 2002. Calcium-independent activation of extracellularly regulated kinases 1 and 2 by angiotensin II in hepatic C9 cells: Roles of protein kinase Cdelta, Src/proline-rich tyrosine kinase 2, and epidermal growth receptor trans-activation. Mol Pharmacol 61(2):343-351.
39. Shah BH, Catt KJ. 2003. A central role of EGF receptor transactivation in angiotensin II-induced cardiac hypertrophy. Trends Pharmacol Sci 24(5):239-244.
40. Shah BH, Catt KJ. 2004. Matrix metalloproteinases in reproductive endocrinology. Trends Endocrinol Metab 15(2):47-49.
41. Shah BH, Farshori MP, Jambusaria A, Catt KJ. 2003a. Roles of Src and epidermal growth factor receptor transactivation in transient and sustained ERK1/2 responses to gonadotropin-releasing hormone receptor activation. J Biol Chem 278(21):19118-19126.
42. Shah BH, Soh JW, Catt KJ. 2003b. Dependence of gonadotropin-releasing hormone-induced neuronal MAPK signaling on epidermal growth factor receptor transactivation. J Biol Chem 278(5):2866-2875.
43. Shah BH, Farshori MP, Catt KJ. 2004. Neuropeptide-induced transactivation of a neuronal epidermal growth factor receptor is mediated by metalloprotease-dependent formation of heparin-binding epidermal growth factor. J Biol Chem 279(1):414-420.
44. Shah BH, Neithardt A, Chu DB, Shah FB, Catt KJ. 2006. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs. J Cell Physiol 206(1):47-57.
45. Stojilkovic SS, Catt KJ. 1995. Novel aspects of GnRH-induced intracellular signaling and secretion in pituitary gonadotrophs. J Neuroendocrinol 7(10):739-757.
46. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ. 2001. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science 292(5517):727-730.
47. Wetzker R, Bohmer FD. 2003. Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat Rev Mol Cell Biol 4(8):651-657.
48. Xing J, Ginty DD, Greenberg ME. 1996. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273(5277):959-963.
49. Xing J, Kornhauser JM, Xia Z, Thiele EA, Greenberg ME. 1998. Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol Cell Biol 18(4):1946-1955.
50. Yamada M, Ikeuchi T, Hatanaka H. 1997. The neurotrophic action and signalling of epidermal growth factor. Prog Neurobiol 51(1):19-37.
51. Zwick E, Bange J, UIlrich A. 2002. Receptor tyrosine kinases as targets for anticancer drugs. Trends Mol Med 8(1):17-23.